References
- McShane H . Susceptibility to tuberculosis – the importance of the pathogen as well as the host. Clin. Exp. Immunol.133(1) , 20–21 (2003).
- Singh SP , MehraNK, DingleyHB, PandeJN, VaidyaMC. Human leukocyte antigen (HLA)-linked control of susceptibility to pulmonary tuberculosis and association with HLA-DR types. J. Infect. Dis.148(4) , 676–681 (1983).
- Bothamley GH , BeckJS, SchreuderGM et al. Association of tuberculosis and M. tuberculosis-specific antibody levels with HLA. J. Infect. Dis. 159(3) , 549–555 (1989).
- Rajalingam R , MehraNK, JainRC, MyneeduVP, PandeJN. Polymerase chain reaction-based sequence-specific oligonucleotide hybridization analysis of HLA class II antigens in pulmonary tuberculosis: relevance to chemotherapy and disease severity. J. Infect. Dis.173(3) , 669–676 (1996).
- Crowle AJ , RossEJ, MayMH. Inhibition by 1,25(OH)2-vitamin D3 of the multiplication of virulent tubercle bacilli in cultured human macrophages. Infect. Immun.55(12) , 2945–2950 (1987).
- Liu PT , StengerS, LiH et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311(5768) , 1770–1773 (2006).
- Rook GA , SteeleJ, FraherL et al. Vitamin D3, γ interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 57(1) , 159–163 (1986).
- Uitterlinden AG , FangY, Van Meurs JB, Pols HA, Van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene338(2) , 143–156 (2004).
- Bornman L , CampbellSJ, FieldingK et al. Vitamin D receptor polymorphisms and susceptibility to tuberculosis in west Africa: a case–control and family study. J. Infect. Dis. 190(9) , 1631–1641 (2004).
- Roy S , FrodshamA, SahaB, HazraSK, Mascie-TaylorCG, HillAV. Association of vitamin D receptor genotype with leprosy type. J. Infect. Dis.179(1) , 187–191 (1999).
- Wilkinson RJ , LlewelynM, ToossiZ et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case–control study. Lancet 355(9204) , 618–621 (2000).
- Babb C , Van Der Merwe L, Beyers N et al. Vitamin D receptor gene polymorphisms and sputum conversion time in pulmonary tuberculosis patients. Tuberculosis (Edinb.)87(4) , 295–302 (2007).
- Selvaraj P , NarayananPR, ReethaAM. Association of vitamin D receptor genotypes with the susceptibility to pulmonary tuberculosis in female patients & resistance in female contacts. Indian J. Med. Res.111 , 172–179 (2000).
- Misra A , HickeyAJ, RossiC et al. Inhaled drug therapy for treatment of tuberculosis. Tuberculosis (Edinb.) 91(1) , 71–81 (2011).
- Verma RK , SinghAK, MohanM, AgrawalAK, MisraA. Inhaled therapies for tuberculosis and the relevance of activation of lung macrophages by particulate drug-delivery systems. Ther. Deliv.2(6) , 753–768 (2011).
- Gordon S . Alternative activation of macrophages. Nat. Rev. Immunol.3(1) , 23–35 (2003).
- Sharma R , MuttilP, YadavAB et al. Uptake of inhalable microparticles affects defence responses of macrophages infected with Mycobacterium tuberculosis H37Ra. J. Antimicrob. Chemother. 59(3) , 499–506 (2007).
- Muttil P , KaurJ, KumarK, YadavAB, SharmaR, MisraA. Inhalable microparticles containing large payload of anti-tuberculosis drugs. Eur. J. Pharm. Sci.32(2) , 140–150 (2007).
- Indian Genome Variation Consortium (IGVC). Genetic landscape of the people of India: a canvas for diseaser gene exploration. J. Genet.87 , 3–20 (2008).
- Olerup O , ZetterquistH. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens39(5) , 225–235 (1992).
- Abhimanyu, Mangangcha IR , JhaP et al. Differential serum cytokine levels are associated with cytokine gene polymorphisms in north Indians with active pulmonary tuberculosis. Infect. Genet. Evol. 11(5) , 1015–1022 (2011).
- Khor CC , VannbergFO, ChapmanSJ et al. CISH and susceptibility to infectious diseases. N. Engl. J. Med. 362(22) , 2092–2101 (2010).
- Semnani RT , MahapatraL, MooreV, SanprasertV, NutmanTB. Functional and phenotypic characteristics of alternative activation induced in human monocytes by interleukin-4 or the parasitic nematode Brugia malayi.Infect. Immun.79(10) , 3957–3965 (2011).
- Vogt G , NathanC. In vitro differentiation of human macrophages with enhanced antimycobacterial activity. J. Clin. Invest.121(10) , 3889–3901 (2011).
- Flesh IEA , KaufmannSHE. Activation of tuberculostatic macrophage functions by γ interferon, interleukin-4, and tumor necrosis factor. Infect. Immun.58 , 2675–2677 (1990).
- Byrd TF . Tumor necrosis factor α (TNF α) promotes growth of virulent Mycobacterium tuberculosis in human monocytes iron-mediated growth suppression is correlated with decreased release of TNF α from iron-treated infected monocytes. J. Clin. Invest.99(10) , 2518–2529 (1997).
- Voskuil MI , SchnappingerD, ViscontiKC et al. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J. Exp. Med. 198(5) , 705–713 (2003).
- Mitra DK , RajalingamR, TanejaV, BhattacharyyaBC, MehraNK. HLA-DR polymorphism modulates the cytokine profile of Mycobacterium leprae HSP-reactive CD4+ T cells. Clin. Immunol. Immunopathol.82(1) , 60–67 (1997).
- Bendtzen K , MorlingN, FomsgaardA et al. Association between HLA-DR2 and production of tumour necrosis factor α and interleukin 1 by mononuclear cells activated by lipopolysaccharide. Scand. J. Immunol. 28(5) , 599–606 (1988).
- Yadav AB , MuttilP, SinghAK et al. Microparticles induce variable levels of activation in macrophages infected with Mycobacterium tuberculosis. Tuberculosis (Edinb.) 90(3) , 188–196 (2010).
▪ Websites
- WHO: Global tuberculosis control – surveillance, planning, financing (2007). www.who.int/tb/publications/global_report/2007/en
- Broad Institute. Haploview. www.broad.mit.edu/mpg/haploview